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Abstract
The significant place in the menopausal syndrome and deficiency of estrogens takes psycho-emotional disorders. 
Psychosomatic disorders, difficulty of adequate evaluation and correction in menopausal women evidence the fact that 
this issue is important today. Severe symptoms of menopausal syndrome at violation of psycho-vegetative sphere appear 
in the early post-menopause, due to final termination of ovarian function and sharply deficiency of estrogens during this 
period. Intravaginal administration of glucosamine hydrochloride to spay female rats has moderate anti-depressant and 
anxiolytic effects, accompanied by reduction of the psycho-emotional behavioral reactions, normalization of locomotor 
activity of animals. As of totality of effects, the estriol reference drug is better than glucosamine hydrochloride. The data 
reveal prospects of vaginal gel glucosamine hydrochloride in the treatment of menopausal disorders of various origins.
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1. Introduction
With increase in life expectancy and the proportion of elderly women in the population, the 
preservation of their life quality has become a pressing medical and social issue of today.
Climacteric is a physiological period, which includes a natural ovarian failure, reduced estro-
gen level, which in its turn results in development of vasomotor, urogenital, endocrine-metabolic and 
psycho-emotional disorders. According to researchers, who have studied the clinical manifestations 
of climacteric in women of 45–54 years, with climacteric syndrome lasting within 5 years, 78.4 % of 
cases show disorders of psycho-emotional sphere [1–3]. 10 % of women experience depression, which 
is one of the most severe and difficult-to-treat symptoms, and 13 % – neurotic disorders, showing 
themselves in tearfulness, irritability, seizures, feeling of fear, anxiety, sleep disorders [4–9].
Pharmacological correction of pathological manifestations of climactericis made withdrugs of 
estrogens, combined preparations containing estrogens with progestins and phytoestrogens. Hormonal 
drugs, while having undoubted efficiency, have a number of contraindications, limiting their use [10, 11].
The use of drugs of metabolite-tropic action, which include glucosamine hydrochloride, can 
be considered as a new approach to prevention and treatment of hypo-estrogenicdisorders. Exper-
imental studies of recent years have shown, that glucosamine hydrochloride,atoral administration 
to animals, increases synthesis of endogenous estrogen, and has neuroprotective and anxiolytic 
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activity [12]. Researches of vaginal pharmaceutical forms of glucosamine hydrochloride have not 
been carried out yet.
The goal of this study is the study of glucosamine hydrochloride effect to psycho-emotional 
and locomotor activity of spay female rats at intravaginal administration.
2. Materials and Methods
The researches have been carried out on non-linear white female rats. The experimental 
animals have been kept in standard vivarium conditions of Central Research Laboratory of the 
National University of Pharmacy (t – 19–24 ºC, humidity less than 50 %, natural light mode “day-
night”). Rats have been kept on a standard diet, had free access to food and water.
Castration (bilateral spay) of females has been performed under ether anesthesia, aseptical-
ly [13]. Sham-operated animals have been subjected to laparotomy and suturing of the wound with-
out removal of ovaries. Vicryl has been used as suture material. The animals have been divided into 
the following groups: 1 – intact control (IC), 2 – sham-operated females (SOF), 3 – control patholo-
gy (CP) – spay animals, 4 – spay rats treated with gel containing 5 % of glucosamine hydrochloride 
(GH) at a dose of 22.7 mg/kg, 5 – spay rats which received a comparative drug – “Ovestin” vaginal 
suppositories (active substance – estriol), produced by Organon Company, the Netherlands, series 
G44874 at a dose of 0.03 mg/kg (E). 6 animals have been taken out of each group. The drugs under 
study have been administered vaginally starting with the 35-th day after castration of females, 
during 28 days. In intact and sham-operated animals, the studied parameters has been determined 
at the stage of the estrous cycle – diestrus [14, 15]. Effect of 5 % gel with glucosamine hydrochlo-
ride and estriol suppository on locomotor activity, orienting-investigative activities and the emo-
tional sphere of the animalshas been studied with the classical test of “open field”. Manifestation of 
anxiety in animals has been examined in the test of “elevated plus maze”, cognitive function has 
been characterized with help of test of “extrapolation disposal” [16]. Antidepressant properties has 
been studied with help of test of “behavioral despair” according to Porsolt [17].
The obtained results have been processed using the standard package of STATISTICA 6.0 
software. Evaluation of reliability of intergroup differences has been made by parametric t – Stu-
dent’s criterion of at normal distribution of data, angular transformation of Fisher taking into ac-
count indicators of an alternative form of reliable interval (p). Differences at p<0.05 has been 
considered statistically significant [18].
Studies were conducted in compliance with the rules of “European Convention for the pro-
tection of vertebrate animals used for experimental and scientific purposes”(Strasbourg, 1986) [19].
3. Results
Results of the test of “open field” are shown in Table 1.
Table 1
Effect of intravaginal administration of gel with 5 % glucosamine hydrochloride and suppositories 
with estriol on indicators of behavioral and emotional reactions in open field test in rats after 
spays(M±m), n=6
Indicators (for 3 min) IC SOF CP GH 22.7 mg/kg Estriol 0.03 mg/kg
Locomotor activity
Cross the squares 9,00±0,52 8,33±0,56 4,33±0,49*/** 7,83±0,31 *** 8,50±0,43***
Tentatively research activities
Mink reflex (holes) 6,50±0,85 4,50±0,72 1,33±0,33*/** 4,88±0,31 */***/+ 6,50±0,67**/***
Vertical columns 5,00±0,68 5,83±0,79 1,17±0,40*/** 4,83±0,60 *** 5,00±0,45***
Vegetative support emotional reactions
Boluses 2,86±0,26 3,17±0,40 4,33±0,42*/** 3,33±0,33+ 2,17±0,31**/***
Urinations 1,50±0,34 2,17±0,31 3,17±0,31*/** 2,00±0,26 *** 2,00±0,26***
Note: Statistically significant differences (p<0.05): * – with group of IC; ** – with group of SOF; *** – with group of 
CP; + – with group of E
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These obtained data suggest that locomotor activity in CP group animals has been significant-
ly reduced: the number of squares crossed decreased 2,1 times in comparison with the intact control. 
There was a significant decrease in orienting-exploratory activity of rats, whichresulted 
in 4,9 times decrease of the number of peeping into the hole and 4,3 times decrease of the num-
ber of vertical columns. At this, there has been a change in the emotional state of animals and 
vegetative support thereof in the form of boluses and urinations increase 1,5 times and 2,1 times 
respectively.
Intravaginal administration of the gel with 5 % glucosamine hydrochloride has resulted in 
a significant increase in locomotor activity and indicators of tentatively research activities, as well 
as in a decrease of symptoms of anxiety in rats against CP group.
A course of treatment with estriol suppositories has contributed to normalization of the 
studied parameters, most of which havereached the level of intact controls.
In the test of “extrapolation disposal”, the data of sham-operated animals group did not vary 
from those in the group of intact rats, from statistical statistic point of view (Table 2).
Table 2
Effect of intravaginal administration of gel with 5 % glucosamine hydrochloride and suppositories 
estriol on cognitive functions of spay female rats in the test of extrapolation disposal (M±m), n=6




Gel GH 22.7 mg/kg 162,83±5,44*/** 83,3***
E 0.03 mg/kg 131,33±12,98*** 100,0***
Note: Statistically significant differences (p<0.05): * – with a group of intact controls; ** – with shamoperated group of 
females; *** – with group of control pathology
Аnimals of CP group, 1,7 times increase of time spent for the solution of the problemhas 
been noted, and there has been a significant decreasein number of female rats, which have coped 
with it, by 66,7 % compared to the intact control.
It is shown, that the administration of gel with 5 % glucosamine hydrochloride has notaf-
fected the speed of problem solution by animals, as evidenced by the absence of statistically sig-
nificant differences with the CP group of rats. At the same time, the drug resulted in an increase 
of the number of animals, which have coped with the problem, to 83,3 %, even though they have 
spent more time.
Time spent for solution of the problem, has been significantly decreased by 37.7 compared to 
a group of CP, against the background of introduction of estriol suppository. At the same time, all 
the animals have coped with this problem. Under these conditions, the use of this drug has reduced 
the time spent by rats for the problem solution by 31.5 seconds, compared to the group of animals 
treated with the gel of glucosamine hydrochloride 5 % (p<0.05).
Analysis of data in Table 3 shows that the test of “elevated plus-maze” in castrated female 
rats has resulted in abruptly increased anxiety and decreased locomotor activity, which is shown 
by a small number of transitions between the branches of the maze. In the group of sham-operated 
animals, latent period of entrance into a branch sleeve and the number of transitions between the 
branches have not varied from those in the group of intact controls, from statistical point of view.
At the same time, the time of sham-operated animals staying in dark branches has beensig-
nificantly increased by 40 sec. (time spent in bright sleeves has been decreased respectively), which 
is probably a result of myocardial stress after surgery.
After vaginal administration of gel with 5 % glucosamine hydrochloride to spayed female 
rats, decrease in symptoms of anxiety was observed as evidenced by the increase in the latent pe-
riod of entry into the dark labyrinth sleeve, which did not statistically differ from that index in IR 
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group. Time spent in bright sleeves did not differ from that in the healthy animals group, but was 30 
seconds more than that in sham-operated. The number of transitions between the sleeves differed 
from that index in all other groups (p<0.05). Animals, treated with hormone replacement therapy, 
had locomotor activity improved and anxiety decreased. Data of all four parameters, which were 
detected in this test, did not statistically differ from the parameters of intact females. It should be 
noted that the time of staying of those animals in dark sleeves was for 30 seconds less, than that of 
sham ones and staying in light sleeves was correspondingly longer.
The study of the antidepressant properties of the studied medications by the test of “behav-
ioral despair” according to Porsolt (Table 4), has shown that intact control animals, whose endo-
crine profilehas not changed, have the lowest total time and the number of immobility acts.
Table 3
Indicators of behavior in female rats in the test of “elevated plus maze” under the influence of the 
gel with 5 % glucosamine hydrochloride and suppositories estriol (M±m), n=6
Groups of animals Latent period enter into dark branch, s
Duration of stay in 
light branch, s
Duration of stay in 
dark branch, s
Number of  
conversions (n)
IC 14,00±2,72 190,83±4,36 109,17±4,36 12,33±0,67
SOF 13,50±2,58 150,83±10,83 * 149,17±10,83 * 10,17±0,54
CP 2,83±0,97 */** 98,33±11,08 */** 201,67±11,08 */** 4,17±0,31 */**
Gel GH 22.7 mg/kg 0,50±1,89*** 180,00±4,66 **/*** 120,00±4,66 **/*** 8,17±0,31 */**/***/+
E 0.03 mg/kg 17,00±3,89 *** 180,83±5,69 **/*** 119,17±5,69 **/*** 11,17±0,60 ***
Note: Statistically significant differences (p <0.05): * – with group of IC; ** – with group of SOF; *** – with group of CP; 
+ – with group of E
Table 4
Effect of gel with 5% glucosamine hydrochloride and suppositories with estriol on cognitive 
function of spay female rats in the test of “behavioral despair according to Porsolt» (M±m), n=6




Gel GH 22,7 mg/kg 113,33±2,47*/**/***/+ 7,00±0,26***
E 0,03 mg/kg 86,67±5,73*** 6,83±0,60***
Note: Statistically significant differences (p<0.05): * – with group of intact controls; ** – with group of sham-operated 
females; *** – with group of disorders control; + – with group of E
In sham-operated animals these indicators have not statistically varied from those of normal 
rats. At the same time, for CP group they have reached a maximum value, 2.7 times higher than val-
ue of interact control, asof total time and 1.7 times as of the number of episodes of immobilization.
Introduction of gel with 5 % glucosamine hydrochloride to castrated rats has resulted in sig-
nificant decrease of total time of immobilization by 90.8 seconds compared to CP, and the number 
of episodes of immobilization has not varied from the healthy animals. The female rats, treated 
with suppositories E, has not shown signs of depression, which has been confirmed by the absence 
of statistically significant differences as of the studied parameters in the intact control.
Thus, the results of the research show that the most pronounced antidepressant effect in 
female rats at psycho-emotional disorders, caused by the removal of gonads, has been provided 
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with E, which has completely reduced their symptoms of depression. Gel with 5 % glucosamine 
hydrochloride has shown moderate antidepressant properties.
4. Discussion of the results
Data of “open field” test suggest that on the background of castration, rats experience de-
velopment of behavioral disorders in the form of lower locomotor activity and indicators of orient-
ing-research activities. At this, gel with 5 % glucosamine hydrochloride has essentially eliminated 
behavioral problems, specific to CP animals group. 
However, as of the effect on indices of the “hole exploratory behavior” and vegetative com-
ponent of emotional reactions manifestations (number of boluses), itwas less effective than the ref-
erence drug. Introduction of E has completely leveled behavioral disorders and vegetative support 
of emotional reactions in experimental animals. Against the background of castration, the females 
have had significantly disturbed cognitive functions. Gel with 5 % glucosamine hydrochloride 
showed a moderate effect in correction of cognitive disorders in animals. At the same time, the 
comparative drug has had most beneficial effect, as in all animals there has been a decrease in the 
time spent by rats for the solution of the disposal problem.
The results of test of “elevated plus maze” has shown that experimental animals of CP 
group sharply have had increased anxiety and decreased locomotor activity. The studied drugs 
have had almost the same anxiolytic effect, and normalizing indirect effect on locomotor activity 
in female rats.
Based on data of test of “behavioral despair” it has been found that the most pronounced 
antidepressant effect at psycho-emotional disorders, caused by the removal of gonads, has been 
shown by E, which at course treatment could reduce symptoms of depression in castrated female 
rats. Gel with 5 % glucosamine hydrochloride has mild antidepressant effect, yielding supposito-
ries containing estriol, 1.3 times as of effect on behavioral responses.
5. Conclusions
Thus, as of the aggregate of obtained data, glucosamine hydrochloride intravaginal admin-
istration to castrated female rats has systemic kinds of actions, showing moderate anxiolytic and 
antidepressant activities, which opens new possibilities of its use for the treatment of climacteric 
syndrome and deficiency of estrogens.
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